Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
18384253 |
Age 24.5 ± 3, Gender ⚥ |
0.56 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 40.8 ± 5.6, Gender ⚥ |
1.1 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 55.6 ± 3.7, Gender ⚥ |
1.73 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
27374292 |
Age [25–35] (median=32), Gender ♀ (Japanese) |
0.800746 (average level of metabolite) |
UHPLC-MS/MS HILIC |
serum |
27374292 |
Age [55–65] (median=60), Gender ♀ (Japanese) |
1.017799 (average level of metabolite) |
UHPLC-MS/MS HILIC |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
30841604 |
Age [25-74], Gender ♀ |
0.14 (β) |
indirect potentiometry |
serum |
30841604 |
Age [45-80], Gender ♀ |
0.24 (β) |
FIA-ESI-MS/MS |
serum |
30841604 |
Age [25-74], Gender ♂ |
0.14 (β) |
indirect potentiometry |
serum |
30841604 |
Age [45-80], Gender ♂ |
0.22 (β) |
FIA-ESI-MS/MS |
serum |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |